Literature DB >> 18513831

Neuronal interaction between melanin-concentrating hormone- and alpha-melanocyte-stimulating hormone-containing neurons in the goldfish hypothalamus.

Sei-Ichi Shimakura1, Kenji Kojima, Tomoya Nakamachi, Haruaki Kageyama, Minoru Uchiyama, Seiji Shioda, Akiyoshi Takahashi, Kouhei Matsuda.   

Abstract

Intracerebroventricular (ICV) administration of melanin-concentrating hormone (MCH) inhibits food intake in goldfish, unlike in rodents, suggesting that its anorexigenic action is mediated by alpha-melanocyte-stimulating hormone (alpha-MSH) but not corticotropin-releasing hormone. This led us to investigate whether MCH-containing neurons in the goldfish brain have direct inputs to alpha-MSH-containing neurons, using a confocal laser scanning microscope, and to examine whether the anorexigenic action of MCH is also mediated by other anorexigenic neuropeptides, such as cholecystokinin (CCK) and pituitary adenylate cyclase-activating polypeptide (PACAP), using their receptor antagonists. MCH- and alpha-MSH-like immunoreactivities were distributed throughout the brain, especially in the diencephalon. MCH-containing nerve fibers or endings lay in close apposition to alpha-MSH-containing neurons in the hypothalamus in the posterior part of the nucleus lateralis tuberis (NLTp). The inhibitory effect of ICV-injected MCH on food intake was not affected by treatment with a CCK A/CCK B receptor antagonist, proglumide, or a PACAP receptor (PAC(1) receptor) antagonist, PACAP((6-38)). ICV administration of MCH at a dose sufficient to inhibit food consumption also did not influence expression of the mRNAs encoding CCK and PACAP. These results strongly suggest that MCH-containing neurons provide direct input to alpha-MSH-containing neurons in the NLTp of goldfish, and that MCH plays a crucial role in the regulation of feeding behavior as an anorexigenic neuropeptide via the alpha-MSH (melanocortin 4 receptor)-signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18513831     DOI: 10.1016/j.peptides.2008.04.009

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  6 in total

1.  The anorexigenic action of the octadecaneuropeptide (ODN) in goldfish is mediated through the MC4R- and subsequently the CRH receptor-signaling pathways.

Authors:  Kouhei Matsuda; Kenji Kojima; Kohei Wada; Keisuke Maruyama; Jérôme Leprince; Marie-Christine Tonon; Minoru Uchiyama; Hubert Vaudry
Journal:  J Mol Neurosci       Date:  2010-03-21       Impact factor: 3.444

2.  Pituitary Adenylate Cyclase-Activating Polypeptide Is Upregulated in Murine Skin Inflammation and Mediates Transient Receptor Potential Vanilloid-1-Induced Neurogenic Edema.

Authors:  Zsuzsanna Helyes; Jozsef Kun; Nora Dobrosi; Katalin Sándor; Jozsef Németh; Aniko Perkecz; Erika Pintér; Krisztina Szabadfi; Balazs Gaszner; Valeria Tékus; Janos Szolcsányi; Martin Steinhoff; Hitoshi Hashimoto; Dora Reglődi; Tamas Bíró
Journal:  J Invest Dermatol       Date:  2015-04-23       Impact factor: 8.551

3.  Comparative transcriptome analysis on the alteration of gene expression in ayu (Plecoglossus altivelis) larvae associated with salinity change.

Authors:  Xin-Jiang Lu; Hao Zhang; Guan-Jun Yang; Ming-Yun Li; Jiong Chen
Journal:  Dongwuxue Yanjiu       Date:  2016-05-18

4.  Effect of intraperitoneal injection of curcumin on food intake in a goldfish model.

Authors:  Ki Sung Kang; Satowa Yahashi; Morio Azuma; Atsushi Sakashita; Seiji Shioda; Kouhei Matsuda
Journal:  J Mol Neurosci       Date:  2010-06-01       Impact factor: 3.444

5.  Pituitary adenylate cyclase-activating polypeptide deficiency enhances oxazolone-induced allergic contact dermatitis in mice.

Authors:  Agnes Kemény; Dóra Reglodi; Renáta Cseharovszky; Hitoshi Hashimoto; Akemichi Baba; János Szolcsányi; Erika Pintér; Zsuzsanna Helyes
Journal:  J Mol Neurosci       Date:  2010-04-23       Impact factor: 3.444

Review 6.  Central pathways integrating metabolism and reproduction in teleosts.

Authors:  Md Shahjahan; Takashi Kitahashi; Ishwar S Parhar
Journal:  Front Endocrinol (Lausanne)       Date:  2014-03-25       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.